San Diego State University logo
Marketing & Communications

Division of University Relations and Development

 

 

        News Release

CONTACT: Aaron Hoskins
SDSU Marketing & Communications
(619) 594-1119
ahoskinsr@mail.sdsu.edu

FOR IMMEDIATE RELEASE

SDSU Heart Institute to Study Cardiac Stem Cells'
Ability to Fight Effects of Aging, Weakening Hearts

SAN DIEGO, Monday, September 15, 2003 — The SDSU Heart Institute has received a $2.3 million grant from the National Institutes of Health to study how stem cells can be used to repair damaged heart tissue after a heart attack and during aging.

Mark Sussman, professor of Biology and a key new member of the SDSU Heart Institute and SDSU BioSciences Center, will lead the SDSU research team.

"Heart failure remains a leading cause of hospital admissions and mortality in the elderly, and current medical approaches fail to treat the underlying cause of the problem, which appears to be diminished stem cell growth," Sussman said. "This study will provide critical information about the role stem cells play in the human heart. Our long-term goal is to provide a method to stimulate cardiac stem cell growth, enhancing a heart's ability to stay strong and resist the effects of aging."

Sussman said the SDSU researchers will combine in vitro and in vivo (laboratory and in-the-body) experiments, using molecular, biochemical, microscopic and transgenic approaches to assess mechanisms that enhance stem cell survival and retard weakening of the heart attributed to aging.

"Dr. Sussman's research has the potential to improve the body's defenses for so many people who are at risk for heart disease, especially as they grow older," said Chris Glembotski, director of the SDSU Heart Institute.

The project represents another major grant for Sussman since his arrival at SDSU in June. He already has received two additional federal grants related to the structural and molecular basis of heart failure as well as an Established Investigator award from the American Heart Association. Prior to his arrival at SDSU, he was an associate professor in the Division of Molecular Cardiovascular Biology at Children's Hospital and Research Foundation in Cincinnati.

The SDSU Heart Institute is partnered in the stem-cell research with New York Medical College. Piero Anversa, director of the Cardiovascular Research Institute at New York Medical College, will direct the clinical trials as the project progresses. Anversa is scheduled to visit SDSU in October.

The SDSU Heart Institute is sponsored by SDSU's College of Sciences and College of Health and Human Services and includes approximately 30 faculty members from a number of health-related disciplines. Its mission is to promote research and teaching programs relating to heart and cardiovascular system performance in health and disease, and to increase awareness of cardiovascular disease and its prevention in the greater San Diego area.

The Heart Institute is a key component of SDSU's BioScience Center, a new, interdisciplinary center that also will be used by the SDSU Center for Microbial Sciences, the California State University Program for Education and Research in Biotechnology (CSUPERB), the SDSU Center for Bio/Pharmaceutical and Biodevice Development (CBBD) and other campus institutes to pursue cutting-edge research designed to help fight health threats ranging from heart disease to emerging infectious diseases to bioterrorism.

San Diego State University is the oldest and largest higher education institution in the San Diego region. Since it was founded in 1897, the university has grown to offer bachelor’s degrees in 79 areas, master’s degrees in 67 areas and doctorates in 14 areas. SDSU’s more than 34,000 students participate in academic curriculum distinguished by direct contact with faculty and an increasing international emphasis that prepares them for a global future. For more information, visit www.sdsu.edu.

###


News Release Archive